Multiple System Atrophy Market Size

Multiple System Atrophy (MSA) Market size was over USD 139.4 million in 2023 and is anticipated to reach USD 247.04 million by 2036, growing at around 4.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of multiple system atrophy is assessed at USD 144.42 million. The growth of the market can be attributed to the growing occurrence of multiple system atrophy across the world, significant shift in people’s lifestyles globally, and rising consumption of alcohol and narcotics. As per the data provided by the Rare Diseases organization, the incidence of multiple system atrophy in the United States alone is 0.6 cases per 100,000 people every year. An estimated 1,900 new cases of the disease occur each year in the country. In addition to these, increasing research and development activities to develop an effective treatment for systemic atrophies and rise in healthcare expenditure in developed and developing nations are also expected to drive growth for the market in the upcoming years. Furthermore, high exposure of people to environmental toxins is projected to offer ample growth opportunities to the market in the near future.